WHO ICTRP trial
Study comparing conduction in median nerve after treatment with Gabapentin or…
CTRI/2018/05/013750 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2018/05/013750 |
|---|---|
| Public title | Study comparing conduction in median nerve after treatment with Gabapentin or Amitriptyline in Diabetic patients suffering from neuropathic pain,and also comparing effectiveness and safety of both drugs |
| Scientific title | Comparative analysis of nerve conduction in median nerve , efficacy and safety of Gabapentin vs Amitriptyline in patients of peripheral neuropathic pain in case of Diabetes mellitus |
| Primary sponsor | Government Medical College Patiala |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: null- Daibetes mellitus with peripheral neuropathic pain |
| Interventions | Intervention1: Gabapentin: Group I patients will be put on Gabapentin at a dose of 300 mg HS orally and subsequent therapeutic response along with any adverse drug reactions (ADRs) observed in patients would be noted. Duration for which… |
| Registration date | Aug 5, 2018 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: